HBX 41,108,
HBX 41108,
HBX-41,108,
HBX-41108,
HBX41,108,
HBX41108,
924296-39-9,
7-Chloro-9-oxo-9H-indeno[1,2-b]pyrazine-2,3-dicarbonitrile,
HBX 41108,
CHEMBL2398212,
7-Chloro-9-oxo-9H-indeno[1,2-b]-pyrazine-2,3-dicarbonitrile,
HBX41108,
9H-Indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 7-chloro-9-oxo-,
BIGPXXAUSQLTQR-UHFFFAOYSA-N,
C13H3ClN4O,
ACMC-20c562,
SCHEMBL1512560,
CTK5H1254,
DTXSID00581703,
BCP08394,
5616AC,
BDBM50436151,
MFCD16251537,
ZINC34984987,
AKOS016010870,
MCULE-5856444395,
QC-8195,
TRA0084150,
KS-0000002G,
AN-16462,
BC665865,
CJ-18619,
AB0061547,
AX8245246,
DB-079303,
TC-060585,
FT-0664852,
7-chloro-9-oxo-indeno[1,2-b]pyrazine-2,3-dicarbonitrile,
7-CHLORO-9-OXO-9H-INDENO[1,2-B]PYRAZINE-2.3-DICARBONITRILE,
D0I9UP,
USP-7 inhibitors, Hybrigenics,
HBX-41108,
USP inhibitors (cancer), Hybrigenics,
USP-7 inhibitors (cancer), Hybrigenics,
USP-9 inhibitors (cancer), Hybrigenics,
B5550,
A13352,
Ubiquitin-specific protease inhibitors (cancer), Hybrigenics,
Ubiquitin-specific protease-7 inhibitors (cancer), Hybrigenics,